These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

690 related items for PubMed ID: 21499212

  • 1. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN.
    Yamaguchi K, Kanemitsu S, Hatori T, Maguchi H, Shimizu Y, Tada M, Nakagohri T, Hanada K, Osanai M, Noda Y, Nakaizumi A, Furukawa T, Ban S, Nobukawa B, Kato Y, Tanaka M.
    Pancreas; 2011 May; 40(4):571-80. PubMed ID: 21499212
    [Abstract] [Full Text] [Related]

  • 2. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakashima A, Sueda T.
    J Surg Oncol; 2009 Jul 01; 100(1):13-8. PubMed ID: 19384908
    [Abstract] [Full Text] [Related]

  • 3. Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: a clinicopathologic comparison with a common type of invasive ductal carcinoma.
    Shimada K, Sakamoto Y, Sano T, Kosuge T, Hiraoka N.
    Pancreas; 2006 Apr 01; 32(3):281-7. PubMed ID: 16628084
    [Abstract] [Full Text] [Related]

  • 4. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Woo SM, Ryu JK, Lee SH, Yoo JW, Park JK, Kim YT, Yoon YB.
    Pancreas; 2008 Jan 01; 36(1):50-5. PubMed ID: 18192881
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm.
    Tanaka T, Kuroki T, Adachi T, Ono S, Hirabaru M, Soyama A, Kitasato A, Takatsuki M, Hayashi T, Eguchi S.
    Pancreas; 2013 Apr 01; 42(3):488-93. PubMed ID: 23146920
    [Abstract] [Full Text] [Related]

  • 7. Mixed ductal-endocrine carcinoma derived from intraductal papillary mucinous neoplasm (IPMN) of the pancreas identified by human telomerase reverse transcriptase (hTERT) expression.
    Hashimoto Y, Murakami Y, Uemura K, Hayashidani Y, Sudo T, Ohge H, Sueda T, Shimamoto F, Hiyama E.
    J Surg Oncol; 2008 Apr 01; 97(5):469-75. PubMed ID: 18161862
    [Abstract] [Full Text] [Related]

  • 8. Clinicopathological features of patients with concomitant intraductal papillary mucinous neoplasm of the pancreas and pancreatic endocrine neoplasm.
    Goh BK, Ooi LL, Kumarasinghe MP, Tan YM, Cheow PC, Chow PK, Chung YF, Wong WK.
    Pancreatology; 2006 Apr 01; 6(6):520-6. PubMed ID: 17124434
    [Abstract] [Full Text] [Related]

  • 9. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas.
    Uehara H, Nakaizumi A, Ishikawa O, Iishi H, Tatsumi K, Takakura R, Ishida T, Takano Y, Tanaka S, Takenaka A.
    Gut; 2008 Nov 01; 57(11):1561-5. PubMed ID: 18477671
    [Abstract] [Full Text] [Related]

  • 10. Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas.
    Ingkakul T, Sadakari Y, Ienaga J, Satoh N, Takahata S, Tanaka M.
    Ann Surg; 2010 Jan 01; 251(1):70-5. PubMed ID: 20009749
    [Abstract] [Full Text] [Related]

  • 11. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas.
    Ishida M, Egawa S, Aoki T, Sakata N, Mikami Y, Motoi F, Abe T, Fukuyama S, Sunamura M, Unno M, Moriya T, Horii A, Furukawa T.
    Pancreas; 2007 Nov 01; 35(4):348-52. PubMed ID: 18090241
    [Abstract] [Full Text] [Related]

  • 12. [Pancreatic ductal carcinoma concomitant with intraductal papillaly mucinous neoplasm].
    Suzuki Y, Sugiyama M, Nakazato T, Yokoyama M, Abe N, Masaki T, Mori T, Hara Y, Ohkura Y.
    Gan To Kagaku Ryoho; 2012 Mar 01; 39(3):347-50. PubMed ID: 22421759
    [Abstract] [Full Text] [Related]

  • 13. Intraductal papillary mucinous neoplasms of the pancreas--predictors of malignancy.
    Fan F, Lai EC, Xie F, Yang JM, Xu F, Kan T, Shen RX, Yang XY, Lau Wan Y, Wu MC.
    Hepatogastroenterology; 2010 Mar 01; 57(99-100):635-9. PubMed ID: 20698241
    [Abstract] [Full Text] [Related]

  • 14. Invasive carcinoma derived from intestinal-type intraductal papillary mucinous neoplasm is associated with minimal invasion, colloid carcinoma, and less invasive behavior, leading to a better prognosis.
    Nakata K, Ohuchida K, Aishima S, Sadakari Y, Kayashima T, Miyasaka Y, Nagai E, Mizumoto K, Tanaka M, Tsuneyoshi M, Oda Y.
    Pancreas; 2011 May 01; 40(4):581-7. PubMed ID: 21499213
    [Abstract] [Full Text] [Related]

  • 15. Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas.
    Furukawa T, Hatori T, Fujita I, Yamamoto M, Kobayashi M, Ohike N, Morohoshi T, Egawa S, Unno M, Takao S, Osako M, Yonezawa S, Mino-Kenudson M, Lauwers GY, Yamaguchi H, Ban S, Shimizu M.
    Gut; 2011 Apr 01; 60(4):509-16. PubMed ID: 21193453
    [Abstract] [Full Text] [Related]

  • 16. Predictors of malignant intraductal papillary mucinous neoplasm of the pancreas.
    Mimura T, Masuda A, Matsumoto I, Shiomi H, Yoshida S, Sugimoto M, Sanuki T, Yoshida M, Fujita T, Kutsumi H, Ku Y, Azuma T.
    J Clin Gastroenterol; 2010 Oct 01; 44(9):e224-9. PubMed ID: 20453661
    [Abstract] [Full Text] [Related]

  • 17. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.
    Serikawa M, Sasaki T, Fujimoto Y, Kuwahara K, Chayama K.
    J Clin Gastroenterol; 2006 Oct 01; 40(9):856-62. PubMed ID: 17016145
    [Abstract] [Full Text] [Related]

  • 18. Pancreatic juice cytology in the diagnosis of intraductal papillary mucinous neoplasm of the pancreas: significance of sampling by peroral pancreatoscopy.
    Yamaguchi T, Shirai Y, Ishihara T, Sudo K, Nakagawa A, Ito H, Miyazaki M, Nomura F, Saisho H.
    Cancer; 2005 Dec 15; 104(12):2830-6. PubMed ID: 16287152
    [Abstract] [Full Text] [Related]

  • 19. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.
    Schnelldorfer T, Sarr MG, Nagorney DM, Zhang L, Smyrk TC, Qin R, Chari ST, Farnell MB.
    Arch Surg; 2008 Jul 15; 143(7):639-46; discussion 646. PubMed ID: 18645105
    [Abstract] [Full Text] [Related]

  • 20. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.
    Michaels PJ, Brachtel EF, Bounds BC, Brugge WR, Pitman MB.
    Cancer; 2006 Jun 25; 108(3):163-73. PubMed ID: 16550572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.